Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 0 | 0 | 0 | 2 | 447 |
| Cost of Goods | N/A | N/A | N/A | 51 | 461 |
| Gross Profit | N/A | N/A | N/A | -49 | -14 |
| Operating Expenses | 1,373 | -651 | 1,968 | 2,297 | 4,710 |
| Operating Income | -1,373 | 202 | -1,968 | -2,295 | -4,263 |
| Other Income | -672 | 394 | 191 | -72 | 1,074 |
| Pre-tax Income | -2,045 | 595 | -1,777 | -2,367 | -3,189 |
| Net Income Continuous | -2,045 | 595 | -1,777 | -2,367 | -3,189 |
| Net Income Discontinuous | -842 | -3,209 | -973 | -1,146 | N/A |
| Net Income | $-2,887 | $-2,613 | $-2,750 | $-3,513 | $-3,189 |
| EPS Basic Total Ops | -8.55 | -29.24 | -13.04 | -17.24 | -16.49 |
| EPS Basic Continuous Ops | -6.00 | -14.43 | -8.40 | -11.24 | -16.16 |
| EPS Basic Discontinuous Ops | -2.55 | -15.89 | -4.65 | -5.25 | N/A |
| EPS Diluted Total Ops | -8.55 | -29.24 | -13.04 | -17.24 | -16.49 |
| EPS Diluted Continuous Ops | -6.00 | -14.43 | -8.40 | -11.24 | -16.16 |
| EPS Diluted Discontinuous Ops | -2.55 | -15.89 | -4.65 | -5.25 | N/A |
| EBITDA(a) | $-1,254 | $669 | $-2,012 | $-2,270 | $-4,243 |